10.1371/journal.pone.0179095

Quantification of γδ T cells and HLA-DR+ NK cells does not predict emergence of new contrast enhancing lesions in MS patients suspending natalizumab treatment

Abstract

Abstract is not available.

Similar works

Full text

thumbnail-image
Last time updated on 12/10/2019

This paper was published in Crossref.

Having an issue?

Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.